ʻO ka Amyotrophic Lateral Sclerosis Als Hoʻomaʻamaʻa Kūʻai Kūʻai ʻo CAGR o 5.7%, Kaohi, Hoʻohui, a me ka wānana (2020-2029)

ka ʻO Amyotrophic Lateral Sclerosis Als Mākeke Lapaʻau ia USD 0.5372 Biliona in 2020. Ke manaʻo ʻia nei e piʻi aʻe kēia helu ma kahi helu hoʻonui makahiki hui o 5.7% waena o 2020-2029. Ke alakaʻi nui ʻia nei kēia mākeke e ka ulu ʻana o ka nui o ka geriatric, ka hoʻonui ʻana i ka ʻike o ALS, a me ka piʻi nui ʻana o ka helu. Eia nō naʻe, hiki i ke kumukūʻai kiʻekiʻe o ka mālama ʻana i ka ALS ke pale i ka ulu ʻana o ka mākeke i ka wā wānana.

Ma muli o ka piʻi ʻana o ka nui o ka momona a puni ka honua, pono e hana i kahi noiʻi hohonu e pili ana i kēia pilikia. Ke hoʻonui nei nā mea hoʻokele mākeke koʻikoʻi i ka ʻai binge, ka ʻai ʻana i ka meaʻai junk, a me ka haʻalele ʻana i ka hoʻomaʻamaʻa maʻamau. Loaʻa i ka hōʻike ka ʻike hou aʻe e pili ana i kēia mau kumuhana a e kālele ana i ka ulu nui o ka pono no ka Amyotrophic Lateral Sclerosis Treatment (ALS).

Ke ulu nei ka makemake:

Manaʻo ʻia ʻo ʻAmelika ʻĀkau e paʻa i kahi mākeke koʻikoʻi i ka honua Amyotrophic Lateral Sclerosis Treatment. ʻO kona piʻi nui ʻana, ka ulu ʻana o ka noi no nā lāʻau lapaʻau ALS, hoʻonui i ka hoʻolimalima mālama ola, nā ʻōnaehana hoʻokumu maikaʻi ʻia, nā kulekele hoihoi maikaʻi, nā holomua ʻenehana, a me nā ʻōnaehana mālama olakino maikaʻi e kōkua i kāna hoʻonui ʻana i ka mākeke. Ma muli o ke kiʻekiʻe o kēia mau maʻi i ka poʻe ʻelemakule. Ua hoʻoholo nā Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, a me CDC e ʻoi aku ka kūleʻa o ka mālama ʻana i ka Amyotrophic Lateral Sclerosis ma ka ʻāina inā pili ka hapa nui ma luna o 50.

E kiʻi i kahi laʻana o kahi hōʻike no ka loaʻa ʻana o ka ʻike piha @ https://market.us/report/amyotrophic-lateral-sclerosis-als-treatment-market/request-sample/

Nā mea hoʻokele:

E alakaʻi ʻia nā mākeke lapaʻau amyotrophic lateral sclerosis honua e ka piʻi ʻana o ka nui o ka geriatric, ka hoʻonui ʻana i ka ʻike o ka ALS, a me ka piʻi nui o ka prevalence. Hiki i nā mea pāʻani mākeke i ka mākeke mālama mālama amyotrophic lateral sclerosis ke hoʻonui i ka holomua ʻenehana a hoʻonui i ka ʻike i nā wahi e ulu ana. ʻO ka mākeke no ka mālama ʻana i ka amyotrophic lateral sclerosis e kaohi ʻia e nā kumukūʻai kiʻekiʻe o ka mālama ʻana i ka ALS a me ka nele o nā limahana akamai.

.

Ua hoʻokaʻawale ʻia ka mākeke no ka mālama ʻana i ka amyotrophic-lateral sclerosis i ka mālama ʻana, ke kahawai hoʻoili, a me ka ʻāina. ʻO ka māhele ʻana o ka mākeke sclerosis amyotrophic-lateral no ka mālama ʻana i hana ʻia i ka lāʻau stem cell, lāʻau lapaʻau, a me nā mea ʻē aʻe. ʻO ka ʻae ʻana o FDA hou i hana i ka māhele lāʻau lapaʻau i ka māhele mākeke nui loa. Hiki ke hoʻokaʻawale ʻia ka ʻāpana kaila hoʻolaha i nā lāʻau lapaʻau halemai a me nā lāʻau kūʻai kūʻai. I ka wā wānana, ʻo ka CAGR kiʻekiʻe loa i manaʻo ʻia ma ka māhele lāʻau kūʻai.

Nā mea e kāohi ai:

Ke ʻike nei ka mākeke i nā kumukūʻai kiʻekiʻe no ka mālama ʻana a me nā ʻoihana haʻahaʻa haʻahaʻa. Ke keakea nei keia i kona ulu ana. Ma waho aʻe o ke kumukūʻai kiʻekiʻe, ʻaʻole ʻike ka mākeke i ka maʻi, a ke kaupalena nei nā ʻano hana hōʻailona kūpono ʻole i kona ulu ʻana.

Ua lohi ka ulu ʻana o ka mākeke e ka nele o nā kulekele uku i hāʻawi ʻia e nā haukapila a me ke aupuni no nā kūlana neurodegenerative e like me ka maʻi o Alzheimer, ka maʻi o Parkinson, a me ka Amyotrophic Lateral Sclerosis (ALS).

Nā Kūlana Kūʻai Kūʻai:

Manaʻo ʻia e ulu nā lāʻau lapaʻau no ka mālama ʻana i ka Amyotrophic Lateral Sclerosis (ALS).

Ua wānana ʻia ʻo nā lāʻau i hoʻohana ʻia i ka mālama ʻana i ka amyotrophic-lateral sclerosis e ʻike koke i ka ulu olakino. Ua ʻae ʻo FDA i ʻelua mau lāʻau no ka mālama ʻana i ka ALS: riluzole a me edaravone. Ua ʻae pū ka FDA iā NeuRx Diaphragm Pacing System. Hoʻohana ʻo ia i nā electrodes implanted a me nā pākaukau e mālama i ka ALS. Eia hou, hiki i ka lāʻau lapaʻau ke kōkua i nā hōʻailona e like me ka spasticity a me ka panic attacks, a me ka ʻeha a me ke kaumaha. ʻO kēia ka hopena i ka ulu nui ʻana o nā lāʻau lapaʻau e mālama ai i ka ALS, e alakaʻi ana i ka ulu ʻana o ka māhele.

Nā ʻoihana nui:

1. ʻO Mitsubishi Tanabe Pharma
2. ʻO ka lāʻau lapaʻau ʻo Takeda
3. Sanofi
4. Haole & Johnson
5. Nā lāʻau lapaʻau ʻo Mylan
6. ʻO Janssen Pharmaceutical

Hoʻokaʻawale:

ʻAno

1. Riluzole
2. Edaravone (Radicava)

noi

1. Nā lāʻau lapaʻau lāʻau
2. Nā Hale kūʻai lāʻau kūʻai
3. Nā hale kūʻai lāʻau lapaʻau pūnaewele

Nā nīnau i nīnau pinepineʻia:

1. He aha ka manawa aʻo no kēia mākeke?
2. He aha ka piʻi o ka ulu ʻana ma ka mākeke ʻo Amyotrophic Lateral Sclerosis?
3. ʻO wai ka ʻāina e ʻike nei i ka ulu wikiwiki loa i ka mākeke ʻo Amyotrophic Lateral Sclerosis?
4. ʻO wai ka ʻāina i loaʻa ka mākeke nui loa o ka Amyotrophic Lateral Sclerosis Treatment Market?

Hōʻike pili:

ʻO ka Global Amyotrophic Lateral Sclerosis Drugs Market Hōʻike e uhi ana i nā mea pāʻani kiʻekiʻe ʻo Boom Drivers & Sales Revenue

ʻO ka Global Amyotrophic Lateral Sclerosis Market Uhi i nā mea hana nui, nā mea hoʻolako, nā mea hoʻolaha 2022-2031

ʻO ka honua Artificial Intelligence i ka mākeke Genomics ʻO nā mea pāʻani koʻikoʻi (ʻoihana ʻoihana a me nā loaʻa kūʻai aku) Ka wānana ʻana i ka wanana 2022-2031

E pili ana iā Market.us

ʻO Market.US (Powered by Prudour Private Limited) kūikawā i ka noiʻi hohonu a me ka nānā ʻana. Ke hōʻike nei kēia ʻoihana iā ia iho ma ke ʻano he kūkākūkā alakaʻi a me ka mea noiʻi mākeke maʻamau a me kahi mea hoʻolako hōʻike noiʻi mākeke syndicated mahalo nui ʻia.

Nā Hoʻokaʻaʻike Hoʻokaʻaʻike:

Hui Hoʻomohala Pāʻoihana honua – Market.us

Market.us (Powered by Prudour Pvt. Ltd.)

Wahi kūkahi: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Kelepona: +1 718 618 4351 (International), Kelepona: +91 78878 22626 (Asia)

Email: [pale ʻia ka leka uila]